Jack Wallace
Stock Analyst at Guggenheim
(0)
# 3394
Out of 5,243 analysts
30
Total ratings
50.00%
Success rate
0.72%
Average return
10 Stocks
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Veeva Systems | Maintains: Strong Buy | 233 249 | 211.32 | 17.83% | 4 | Oct 1, 2024 | |
WW International | Maintains: Buy | 12 6 | 1.3 | 361.54% | 3 | Aug 2, 2024 | |
R1 RCM | Maintains: Buy | 17 15 | n/a | n/a | 4 | Apr 5, 2024 | |
Hims & Hers Health | Maintains: Strong Buy | 15 17 | 26.75 | -36.45% | 4 | Feb 27, 2024 | |
Health Catalyst | Upgrades: Buy | 14 | 5.78 | 142.21% | 3 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 253 220 | 196.91 | 11.73% | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 22 | n/a | n/a | 4 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 40 | 26.89 | 48.75% | 5 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 | 8.64 | 1057.41% | 1 | Mar 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Apr 14, 2022 |